Related Party Transactions (Tables)

9 Months Ended

Sep. 30, 2023

Related Party Transactions [Abstract]

Schedule of Related Party Transactions

Our consolidated statements of income include sales to and purchases from unconsolidated affiliates in the ordinary course of business as follows (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Sales to unconsolidated affiliates	$	4,070	$	9,490	$	14,843	$	24,359
Purchases from unconsolidated affiliates(a)(b)	$	884,886	$	614,889	$	3,072,374	$	1,146,329

(a)Purchases from unconsolidated affiliates primarily relate to spodumene purchased from the Company’s Windfield joint venture.

(b)Cost of goods sold on the consolidated statements of income included purchases from related unconsolidated affiliates of $634.7 million and $214.0 million during the three-month periods ended September 30, 2023 and 2022, respectively, and $1.4 billion and $372.6 million for the nine-month periods ended September 30, 2023 and 2022, respectively.

Our consolidated balance sheets include accounts receivable due from and payable to unconsolidated affiliates in the ordinary course of business as follows (in thousands):

	September 30, 2023		December 31, 2022
Receivables from unconsolidated affiliates	$	2,419	$	21,495
Payables to unconsolidated affiliates(a)	$	795,088	$	518,377

(a)Payables to unconsolidated affiliates primarily relate spodumene purchased from the Company’s Windfield joint venture under normal payment terms.